Susquehanna Portfolio Strategies, LLC Akero Therapeutics, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 15,756 shares of AKRO stock, worth $850,508. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,756Holding current value
$850,508% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
300Shares Held
92.1MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$364 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$310 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$302 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$296 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$244 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.51B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...